49
Participants
Start Date
October 30, 2025
Primary Completion Date
April 30, 2029
Study Completion Date
April 30, 2029
CISGEM + Rilvegostomig
"Administration of 4 cycles pre-operative and 4 cycles post-operative of Cisplatine associated to Gemcitabine with rilvegostomig~RILVEGOSTOMIG : For each cycle one administration at D1 every 3 weeks~• 750 mg IV administration over 60 minutes (up to a total of 90 minutes). CISGEM: For each cycle administration at D1 and D8 every 3 weeks~* Cisplatine 25 mg/m² in 1 hour IV in 1000 ml NaCl 0,9 % then 500 ml NaCl 0,9 %~* Gemcitabine 1000 mg/m² en 30 mn IV dans 250 ml NaCl 0,9 %"
Nancy Chru, Nancy
Chu Caen Normandie, Caen
Centre Gf Leclerc, Dijon
Chu de Dijon, Dijon
Chu Grenoble Alpes, Grenoble
Chu Dupuytren, Limoges
Hopital de La Timone Ap-Hm, Marseille
Hopital Prive Du Confluent, Nantes
Chu de Poitiers, Poitiers
Federation Francophone de Cancerologie Digestive
OTHER